Structure of Mavacamten
CAS No.: 1642288-47-8
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
MYK-461 is a myosin inhibitor potentially for the treatment of hypertrophic cardiomyopathy, and can reduce contractility by decreasing the adenosine triphosphatase activity of the cardiac myosin heavy chain.
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 1642288-47-8 |
Formula : | C15H19N3O2 |
M.W : | 273.33 |
SMILES Code : | O=C1N(C(C)C)C(C=C(N[C@H](C2=CC=CC=C2)C)N1)=O |
MDL No. : | MFCD31746877 |
GHS Pictogram: |
![]() ![]() ![]() |
Signal Word: | Danger |
Hazard Statements: | H302-H319-H332-H372-H400 |
Precautionary Statements: | P260-P264-P270-P273-P280-P301+P312+P330-P304+P312-P305+P351+P338-P314-P337+P313-P391-P501 |
Class: | 9 |
UN#: | 3077 |
Packing Group: | Ⅲ |
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
Adult rat ventricular cardiomyocytes | 0.18 µM (IC50) | MYK-461 reduced fractional shortening in a dose-dependent manner without altering calcium transients | PMC4784435 | |
Mouse cardiac myofibrils | 0.3 µM (IC50) | MYK-461 reduced ATPase activity in a dose-dependent manner, with maximal doses (>10 µM) reducing the ATPase rate by ~90% | PMC4784435 | |
Rabbit psoas myofibrils | 0.1-50 µM | Mavacamten decreased the kinetics of force development in fast skeletal myofibrils, while it had no effect in human ventricular myofibrils. | PMC8077167 | |
Human ventricular myofibrils | 0.1-50 µM | Mavacamten had a fast, fully reversible, and dose-dependent negative effect on maximal Ca2+-activated isometric force at 15°C, which can be explained by a sudden decrease in the number of heads functionally available for interaction with actin. | PMC8077167 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
Mice | HCM Mice models expressing α-cardiac myosin heavy chain missense mutations (R403Q, R719W, or R453C) | Oral administration in drinking water | 2.5 mg/kg | Daily administration for 20 to 26 weeks (preventive treatment) or 4 weeks (reversal treatment) | MYK-461 reduced cardiac contractility in a dose-dependent manner, prevented or ameliorated left ventricular hypertrophy (LVH), reduced myocardial fibrosis and cardiomyocyte disarray, and improved gene expression profiles | PMC4784435 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT06112743 | Cardiomyopathy, Hypertrophic | PHASE4 | RECRUITING | 2026-07-31 | Local Institution - 0087, West... More >> Hollywood, California, 90048-1804, United States|Piedmont Hospital, Atlanta, Georgia, 30309, United States|Local Institution - 0091, Honolulu, Hawaii, 96813-2414, United States|Local Institution - 0093, Boston, Massachusetts, 02114, United States|University Hospitals Cleveland Medical Center - 11100 Euclid Ave, Cleveland, Ohio, 44106, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, 15212-4756, United States|Houston Methodist Hospital, Houston, Texas, 77030, United States|Local Institution - 0035, Murray, Utah, 84107-5701, United States|Local Institution - 0075, Caba, Buenos Aires, 0, Argentina|Local Institution - 0076, Ciudad Autónoma de Buenos Aires, Buenos Aires, C1093AAS, Argentina|Local Institution - 0079, Pilar, Buenos Aires, B1629ODT, Argentina|Local Institution - 0077, Ciudad De Cordoba, Cordoba, X5000JHGQ, Argentina|Local Institution - 0074, Rosario, Santa FE, S2000GAP, Argentina|Local Institution - 0080, Buenos Aires, C1181ACH, Argentina|Royal Prince Alfred Hospital, Camperdown, New South Wales, 2050, Australia|Local Institution - 0082, Darlinghurst, New South Wales, 2010, Australia|Prince Charles Hospital, Chermside, Queensland, 4032, Australia|Local Institution - 0022, Herston, Queensland, 4029, Australia|The Alfred Hospital, Melbourne, Victoria, 3004, Australia|Local Institution - 0057, Klagenfurt am W?rthersee, K?rnten, 9020, Austria|Local Institution - 0032, Braunau am Inn, Upper Austria, 5280, Austria|Local Institution - 0028, Graz, 8036, Austria|Local Institution - 0088, Wien, 1090, Austria|Local Institution - 0007, Wien, 1100, Austria|Local Institution - 0084, Anderlecht, Brussels, 1070, Belgium|Local Institution - 0070, Bruxelles, Brussels, 1200, Belgium|Local Institution - 0069, Jette, Brussels, 1090, Belgium|Local Institution - 0092, Genk, Limburg, 3600, Belgium|Local Institution - 0083, Leuven, Vlaams Brabant, 3000, Belgium|Local Institution - 0071, Roeselare, West-Vlaanderen, 8800, Belgium|Local Institution - 0004, Calgary, Alberta, T2N 1N4, Canada|Local Institution - 0001, Montreal, Quebec, H1T 1C8, Canada|Local Institution - 0068, Quebec, G1V 4G5, Canada|Local Institution - 0016, Broumov, Královéhradecky Kraj, 550 01, Czechia|Local Institution - 0053, Trinec, Moravskoslezsky Kraj, 739 61, Czechia|Local Institution - 0050, Prague, Praha, Hlavní Mesto, 140 21, Czechia|Local Institution - 0011, Praha 2, Praha, Hlavní Mesto, 128 21, Czechia|Local Institution - 0052, Brno, 656 91, Czechia|Local Institution - 0073, Helsinki, Etel?-Suomen L??ni, 00290, Finland|Local Institution - 0072, Turku, L?nsi-Suomen L??ni, 20540, Finland|Local Institution - 0031, Grenoble, 38043, France|Local Institution - 0014, Paris, 75015, France|Local Institution - 0026, Pessac, 33604, France|Local Institution - 0002, Rennes, 35000, France|Local Institution - 0047, Giessen, Hessen, 35392, Germany|Local Institution - 0034, G?ttingen, Niedersachsen, 37075, Germany|Local Institution - 0040, Bad Oeynhausen, Nordrhein-Westfalen, 32545, Germany|Local Institution - 0023, Berlin, 12203, Germany|Local Institution - 0009, Athina, Attiki, 115 27, Greece|Local Institution - 0008, Athina, Attiki, 176 74, Greece|Local Institution - 0059, Chaidari, Athens, Attiki, 124 62, Greece|Local Institution - 0037, Heraklion, 71110, Greece|Local Institution - 0006, Thessaloniki, 546 36, Greece|Local Institution - 0021, Thessaloniki, 546 42, Greece|Local Institution - 0042, Pécs, Baranya, 7621, Hungary|Local Institution - 0054, Szeged, Csongrád, 6720, Hungary|Local Institution - 0020, Balatonfüred, Veszprém, 8230, Hungary|Local Institution - 0019, Budapest, 1083, Hungary|Local Institution - 0013, Budapest, 1096, Hungary|Local Institution - 0041, Budapest, 1097, Hungary|Local Institution - 0063, Budapest, 1134, Hungary|Local Institution - 0038, Milano, Lombardia, 20149, Italy|Local Institution - 0060, Milano, Lombardia, 20162, Italy|Local Institution - 0056, Pavia, Lombardia, 27100, Italy|Local Institution - 0048, Firenze, Toscana, 50139, Italy|Local Institution - 0062, Pisa, Toscana, 56124, Italy|Local Institution - 0051, Arezzo, 52100, Italy|Local Institution - 0018, Warszawa, Mazowieckie, 02-507, Poland|Local Institution - 0094, Warszawa, Mazowieckie, 04-628, Poland|Local Institution - 0044, Katowice, Slaskie, 40-555, Poland|Local Institution - 0049, Zabrze, Slaskie, 41-800, Poland|Local Institution - 0064, Bialystok, 15-276, Poland|Local Institution - 0012, Lódz, 93-338, Poland|Local Institution - 0043, Palma de Mallorca, Baleares, 07198, Spain|Local Institution - 0046, Malaga, Málaga, 29010, Spain|Local Institution - 0030, Barcelona, 08035, Spain|Local Institution - 0089, Madrid, 28034, Spain|Local Institution - 0081, Madrid, 28035, Spain|Local Institution - 0045, Salamanca, 37007, Spain|Local Institution - 0039, Sevilla, 41013, Spain|Luzerner Kantonsspital (LUKS), Luzern, Luzern (de), 6000, Switzerland|Istituto Cardiocentro Ticino, Lugano, Ticino (it), 6900, Switzerland|Local Institution - 0055, Lugano, Ticino (it), 6900, Switzerland|Local Institution - 0036, Bern, 3010, Switzerland|H?pitaux Universitaires de Genève, Geneva, 1205, Switzerland|Universit?tsspital Zürich, Zürich (de), 8091, Switzerland|Local Institution - 0027, Belfast, Antrim, BT16 1RH, United Kingdom|Leeds General Infirmary, Leeds, Yorkshire, LS1 3EX, United Kingdom|Local Institution - 0010, London, SW17 0QT, United Kingdom Less << |
NCT05135871 | Hypertrophic Cardiomyopathy | PHASE1 | COMPLETED | 2022-02-28 | Huashan Hospital Fudan Univers... More >>ity, Shanghai, Shanghai, 200040, China Less << |
NCT05362045 | Healthy Participants | PHASE1 | COMPLETED | 2022-08-19 | Clinical pharmacology of Miami... More >>, Miami, Florida, 33014, United States|Advanced Pharma CR, LLC, Miami, Florida, 33147, United States|QPS Springfield, Springfield, Missouri, 65802, United States|Ppd Phase I Clinic, Austin, Texas, 78744, United States Less << |
NCT06549608 | Hypertrophic Cardiomyopathy | ACTIVE_NOT_RECRUITING | 2025-04-18 | St. Paul's Hospital, Vancouver... More >>, British Columbia, Canada Less << | |
NCT05414175 | Cardiomyopathy, Hypertrophic O... More >>bstructive Less << | PHASE3 | ACTIVE_NOT_RECRUITING | 2026-03-06 | Local Institution - 0020, Uwaj... More >>ima, Ehime, 798-8510, Japan|Local Institution - 0026, Himeji-Shi, Hyogo, 672-8044, Japan|Local Institution - 0016, Kobe-shi, Hyogo, 650-0047, Japan|Local Institution - 0017, Tsukuba-Shi, Ibaraki, 305-0005, Japan|Local Institution - 0023, Kanazawa-shi, Ishikawa, 920-8641, Japan|Local Institution - 0019, Yokohama, Kanagawa, 227-8501, Japan|Local Institution - 0015, Nankoku-shi, Kochi, 783-8505, Japan|Local Institution - 0028, Tsu-Shi, MIE, 514-0001, Japan|Local Institution - 0027, Sendai, Miyagi, 980-8574, Japan|Local Institution - 0011, Suita-Shi, Osaka, 565-0871, Japan|Local Institution - 0014, Suita, Osaka, 564-8565, Japan|Local Institution - 0012, Hamamatsu-city, Shizuoka, 431-3192, Japan|Local Institution - 0010, Bunkyo-Ku, Tokyo, 113-0033, Japan|Local Institution - 0009, Chuo-Ku, Tokyo, 104-0044, Japan|Local Institution - 0003, Fuchu-Shi, Tokyo, 1830003, Japan|Local Institution - 0001, Itabashi-Ku, Tokyo, 173-0003, Japan|Local Institution - 0007, Koto-Ku, Tokyo, 135-0061, Japan|Local Institution - 0005, Shinjuku-Ku, Tokyo, 160-8582, Japan|Local Institution - 0013, Shinjuku-ku, Tokyo, 162-8666, Japan|Local Institution - 0018, Osaka, 558-8558, Japan Less << |
NCT06338202 | Obstructive Hypertrophic Cardi... More >>omyopathy (oHCM) Less << | RECRUITING | 2024-11-01 | London Health Science Centre (... More >>LHSC), London, Ontario, N6A 5A5, Canada Less << | |
NCT06551129 | Obstructive Hypertrophic Cardi... More >>omyopathy Less << | RECRUITING | 2027-06-30 | Analysis Group Inc., Boston, M... More >>assachusetts, 02199, United States Less << | |
NCT05719805 | Healthy Participants | PHASE1 | COMPLETED | 2023-07-25 | Local Institution - 0001, Miam... More >>i, Florida, 33136, United States|Local Institution - 0002, Saint Paul, Minnesota, 55114, United States Less << |
NCT05939700 | Breastfeeding|Hypertrophic Car... More >>diomyopathy|Pregnancy Related Less << | RECRUITING | 2025-04-27 | The Mavacamten Pregnancy Surve... More >>illance Program, PPD Inc, Wilmington, North Carolina, 28401-3331, United States Less << | |
NCT06146660 | Obstructive Hypertrophic Cardi... More >>omyopathy Less << | RECRUITING | 2026-11-30 | Local Institution - 0001, Seou... More >>l, 06234, Korea, Republic of|Novotech Laboratory Korea Co., Ltd., Seoul, 06234, Korea, Republic of Less << |
Tags: Mavacamten | MYK461 | SAR439152 | MYK 461 | MYK-461 | SAR439152 | SAR 439152 | SAR-439152 | Myosin | 1642288-47-8
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL